Change Location × Atlanta

    Recent Locations

      Systemic Sclerosis With Pulmonary Involvement: Improving Diagnosis and Advances in Treatment in Atlanta

      • Systemic Sclerosis With Pulmonary Involvement: Improving Diagnosis and Advances in Treatment Photo #1
      1 of 1
      November 12, 2019

      Tuesday   6:00 PM

      International Ballroom F; North Tower, M2 , 100 CNN Center NW
      Atlanta, Georgia

      • No Performers Listed
      Systemic Sclerosis With Pulmonary Involvement: Improving Diagnosis and Advances in Treatment

      This program is intended for 2019 ACR/ARP Annual Meeting attendees only. Activity Chair Elana J. Bernstein, MD, MSc Assistant Professor of MedicineProgram Director, Columbia University/New York-Presbyterian Scleroderma ProgramColumbia University College of Physicians & SurgeonsNew York, NY Faculty Richard M. Silver, MDDistinguished University ProfessorDivision of RheumatologyMedical University of South CarolinaCharleston, SC Elizabeth R. Volkmann, MD, MSAssistant Professor of MedicineFounder, Co-director of UCLA CTD-ILD ProgramUniversity of California, Los AngelesDavid Geffen School of MedicineLos Angeles, CA Overview Systemic sclerosis (SSc) is a disabling autoimmune disorder that can cause diffuse fibrosis and vascular abnormalities in the skin, joints, and internal organs. Affecting approximately 2 million people worldwide, SSc is challenging to diagnose due to its nonspecific symptomatology and rare nature. Up to 90% of patients with SSc will have pulmonary involvement, and the presence of interstitial lung disease (SSc-ILD) is associated with poor prognosis. Currently, no disease-modifying therapies are available for treating SSc-ILD, but several agents approved for idiopathic pulmonary fibrosis are in late-stage clinical development. In this live satellite symposium, experts will review the presentation and workup of SSc, while addressing the burden of disease, as well as evaluate the clinical evidence for current and emerging treatment options. Faculty will also address the impact of SSc-ILD on patient prognosis and emphasize the importance of multidisciplinary care for timely identification of patients who may benefit from new treatments.  Agenda 6:00 PMRegistration and Dinner 6:30 PM Introduction and PollingElana J. Bernstein, MD, MSc 6:35 PM Understanding the Burden of Systemic Sclerosis – The Need for Timely DiagnosisElizabeth R. Volkmann, MD, MS 6:55 PM Available and Emerging Management Options for Patients With Systemic SclerosisRichard M. Silver, MD 7:20 PM Clinical Cases in Systemic SclerosisElana J. Bernstein, MD, MSc 7:45 PMPosttest 7:50 PMQuestion and Answer 8:00 PMConclusion Learning Objectives Upon successful completion of this activity, participants should be better able to: Evaluate the clinical symptomology and appropriate medical workup for SSc to better identify patients in a timely manner and refer to a specialist as warranted. Examine the burden of SSc on patient quality of life and the impact of pulmonary involvement on patients’ outcomes. Examine the latest clinical evidence regarding agents for the treatment of SSc, including the impact on skin score, lung function, and quality of life. Review the importance of multidisciplinary care for identifying patients with SSc and worsening pulmonary involvement who may benefit from emerging treatment options. Target Audience The intended audience for this activity is rheumatologists and other health care professionals involved in the management of patients with SSc. This continuing medical education activity is provided by Vindico Medical Education. This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. This is not an official program of the American College of Rheumatology. This symposium will be conducted during the 2019 ACR/ARP Annual Meeting. Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Vindico Medical Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience. Faculty, topics, program schedule, and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program committee.

      Categories: Health & Wellness

      Event details may change at any time, always check with the event organizer when planning to attend this event or purchase tickets.